Polyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: A randomized-controlled clinical trial

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 8, 2006, Pages 1259-1265

  Rendeli, C ^a,b   Ausili, E ^a   Tabacco, F ^a   Focarelli, B ^a   Pantanella, A ^a   Di Rocco, C ^a   Genovese, O ^a   Fundaro C ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LACTULOSE; MACROGOL 4000;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; FECES INCONTINENCE; FEMALE; FLATULENCE; HARD FECES; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGOMYELOCELE; NAUSEA; NEUROGENIC CONSTIPATION; NEUROLOGIC DISEASE; PALATABILITY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANALYSIS OF VARIANCE; CATHARTICS; CHILD; CONSTIPATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LACTULOSE; MALE; MENINGOMYELOCELE; POLYETHYLENE GLYCOLS; SOLVENTS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 33646870589     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02872.x     Document Type: Article

References (27)

1. Pashankar D Bishop WP. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. J Pediar Gastroenterol Nutr 2001 139: 428 32.
2. Attar A Lemann M Ferguson A, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut 1999 44: 226 30.
3. Bouhnik Y Neut C Raskina L et al. Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation. Alimnt Pharmacol Ther 2004 19: 889 17.
4. Botto L Moore CA Khoury MJ Erickson JD. Neural tube defects. N Engl J Med 1999 341 : 1509 19.
5. Mitchell LE Adzick NS Melchionne J Pasquariello PS Sutton LN Whitehead AS. Spina bifida. Lancet 2004 364 : 1885 95.
6. O'Rahilly R Muller F. The two sites of fusion of the neural folds and the two neuropores in the human embryo. Teratol 2002 65 : 162 70.
7. International Clearinghouse for Birth Defects Monitoring Systems. Annual Report 1998 with Data for 1996. Rome : International Centre for Birth Defects, 1998.
8. Palmer LS Richards I Kaplan WE. Transrectal electrostimulation therapy for neuropathic bowel dysfunction in children with myelomeningocele. J Urol 1997 157: 1449 52.
9. Webb HW Barraza MA Stevens PS Crump JM Erhard M. Bowel dysfunction in spina bifida - an American experience with the ACE procedure. Eur J Pediatr Surg 1998 8 S1 37 38.
10. Freedman MD Schwartz HJ Roby R Fleisher S. Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: a double-blinded placebo-controlled trial. J Clin Pharm 1997 37: 904 7.
11. Corazziari E Badiali D Bazzocchi G, et al. Long term efficacy, safety, and tolerability of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut 2000 46: 522 6.
12. Hammer HF Santa Ana CA Schiller LR, et al. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J Clin Invest 1989 84 : 1056 62.
13. Voskuijl W de Lorijn F Verwijs W et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut 2004 53 : 1590 4.
14. Di Palma JA DeRidder PH Orlando RC. A randomized, placebo-controlled, multi centre study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 2000 95 : 446 50.
15. Staiano A. Use of polyethylene glycol solution in functional and organic constipation in children. Ital J Gastroenterol Hepatol 1999 31 S3 S260 3.
16. Drossman DA (ed.) The Functional Gastrointestinal Disorders. Boston : Little, Brown, 1994 : 115 73.
17. Staiano A Del Giudice E Farinucci A. Diagnosis and management of upper gastrointestinal dysfunction in children with neurological and neuromuscular diseases. In: Corazziari E, ed. Neuro Gastroenterology. Berlin-New York : De Gruyter, 1996 : 349 57.
18. Baker SS Liptak GS Colletti RB. Constipation in infants and children: evaluation and treatment-a medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Ped Gastroenterol Nutr 1999 29 : 612 26.
19. Thompson WG. Laxatives: clinical pharmacology and practical use. Drugs 1980 19 : 49 58.
20. Dupont C Leluyer B Maamri N, et al. Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. J Pediatr Gastroenterol Nutr 2005 41 : 625 33.
21. Chaussade S. Mechanisms of action of low doses of polyethylene glycol in the treatment of functional constipation. Ital J Gastroenterol Hepatol 1999 31 S3 S42 44.
22. Costa M Brookes SJK Steele PA Gibbins I Burcher E Kandiah CJ. Neurochemical classification of myenteric neurons in the guinea-pig ileum. Neuroscience 1996 75 : 949 67.
23. Holzer P Holzer-Petsche U. Tackykinins in the gut. Part I. Expression, release and motor function. Pharmacol Ther 1977 73 : 173 217.
24. Loening-Baucke V. Polyethylene glycol without electrolytes for children with constipation and encopresis. J Pediatr Gastroenterol Nutr 2002 34 : 372 7.
25. Tonini M. Polyethylene glycol as non-absorbable prokinetic agent in the lower gastrointestinal tract. Ital J Gastroenterol Hepatol 1999 31 S3 S238 41.
26. Pashankar DS Bishop WP. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. J Pediatr 2001 139 : 428 32.
27. Gremse DA hixon J Crutchfield A. Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children. Clin Pediat (Phila) 2002 41 : 225 9.